Literature DB >> 8737051

Modified beta-cyclodextrin (SBE7-beta-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits.

P Jarho1, K Järvinen, A Urtti, V J Stella, T Järvinen.   

Abstract

The complexation of pilocarpine prodrug, O,O'-dipropionyl-(1,4-xylylene) bispilocarpate, with various beta-cyclodextrin (beta-CyD) derivatives was studied by the phase solubility method. The effects of coadministered sulphobutyl ether beta-CyD (SBE7-beta-CyD) with and without poly(vinyl alcohol) (PVA) on the miotic response and eye irritation of the prodrug were investigated in pigmented rabbits. The pilocarpine prodrug formed 1:1 inclusion complexes with variably substituted sulphobutyl ether derivatives of beta-CyD (SBE4-beta-CyD and SBE7-beta-CyD), and 1:1 and 1:2 complexes with hydroxypropyl-beta-CyD (HP-beta-CyD) at pH 7-4. Coadministered SBE7-beta-CyD eliminated the eye irritation due to the pilocarpine prodrug, but also decreased the miotic response. Ocular absorption of the prodrug was improved by increasing the viscosity of prodrug/SBE7-beta-CyD solution with PVA without inducing any eye irritation. Eye irritation due to viscous prodrug/SBE7-beta-CyD solutions was comparable with isotonic NaCl solution. We conclude that administration of pilocarpine prodrug in viscous SBE7-beta-CyD solution decreases substantially eye irritation while ocular absorption is not affected.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8737051     DOI: 10.1111/j.2042-7158.1996.tb05914.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  9 in total

Review 1.  Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery.

Authors:  Abeer M Al-Ghananeem; Peter A Crooks
Journal:  Molecules       Date:  2007-03-08       Impact factor: 4.411

Review 2.  Cyclodextrins: their future in drug formulation and delivery.

Authors:  V J Stella; R A Rajewski
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

3.  Effects of topical alpha-substituted anandamides on intraocular pressure in normotensive rabbits.

Authors:  D W Pate; K Järvinen; A Urtti; P Jarho; V Mahadevan; T Järvinen
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

4.  Diclofenac-beta-cyclodextrin binary systems: physicochemical characterization and in vitro dissolution and diffusion studies.

Authors:  Maria Letizia Manca; Marco Zaru; Guido Ennas; Donatella Valenti; Chiara Sinico; Giuseppe Loy; Anna Maria Fadda
Journal:  AAPS PharmSciTech       Date:  2005-10-22       Impact factor: 3.246

5.  Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovir.

Authors:  Giridhar S Tirucherai; Ashim K Mitra
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

6.  Biocompatibility and drug release behavior of chitosan/poly (vinyl alcohol) corneal shield in vivo.

Authors:  Guo-Xing Li; Xin Gu; Hui-Yang Song; Kai-Hui Nan; Hao Chen
Journal:  Int J Clin Exp Med       Date:  2015-08-15

7.  Cyclodextrins in delivery systems: Applications.

Authors:  Gaurav Tiwari; Ruchi Tiwari; Awani K Rai
Journal:  J Pharm Bioallied Sci       Date:  2010-04

Review 8.  Polysaccharides in Ocular Drug Delivery.

Authors:  Natallia Dubashynskaya; Daria Poshina; Sergei Raik; Arto Urtti; Yury A Skorik
Journal:  Pharmaceutics       Date:  2019-12-24       Impact factor: 6.321

Review 9.  Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review.

Authors:  Marcelo Luís Occhiutto; Raul C Maranhão; Vital Paulino Costa; Anastasios G Konstas
Journal:  Adv Ther       Date:  2019-12-10       Impact factor: 3.845

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.